Precision Medicine for Lyme Recovery

🧬 New Publication Alert!

We are proud to announce the release of our latest peer-reviewed review article in the American Journal of Biomedical Science & Research:

💡 Why This Matters:

Post-Treatment Lyme Disease Syndrome (PTLDS) affects nearly 1 in 5 Lyme disease patients with persistent fatigue, cognitive dysfunction, pain, and autonomic disturbances—despite antibiotic therapy. This breakthrough review offers an integrative, regenerative medicine model that redefines treatment possibilities.

🔬 Key Takeaways:

✔️ Highlights the immunological roots of PTLDS: molecular mimicry, immune dysregulation, and persistent inflammation

✔️ Proposes a precision-based triad of care:

1️⃣ Organ- and tissue-specific regenerative repair (e.g. using MSCs, neural progenitors, exosomes)
2️⃣ Neuroimmune modulation to enhance cognitive and autonomic recovery
3️⃣ Antigen-Adaptive Selective Immunotherapy (AASI) to reset immune tolerance to Borrelia and self-antigens

✔️ Synthesizes emerging clinical and preclinical evidence on stem cell and exosome-based therapies

✔️ Builds a holistic framework for immune recalibration, tissue healing, and lasting recovery

This publication paves the way for a personalized, systems medicine approach to one of the most elusive chronic infectious syndromes today.

📖 Learn more about the publication here:
🔗https://european-wellness.eu/publications/immunologic-reset-and-regenerative-repair/

📖 Full Access:
🔗 https://biomedgrid.com/pdf/AJBSR.MS.ID.003606.pdf